These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
442 related articles for article (PubMed ID: 34243101)
1. Beneficial effects of a nano formulation of pomegranate seed oil, GranaGard, on the cognitive function of multiple sclerosis patients. Petrou P; Ginzberg A; Binyamin O; Karussis D Mult Scler Relat Disord; 2021 Sep; 54():103103. PubMed ID: 34243101 [TBL] [Abstract][Full Text] [Related]
2. Brief international cognitive assessment for multiple sclerosis (BICAMS): A danish validation study of sensitivity in early stages of MS. Marstrand L; Østerberg O; Walsted T; Skov AC; Schreiber KI; Sellebjerg F Mult Scler Relat Disord; 2020 Jan; 37():101458. PubMed ID: 31683230 [TBL] [Abstract][Full Text] [Related]
3. A preliminary validation of the brief international cognitive assessment for multiple sclerosis (BICAMS) tool in an Irish population with multiple sclerosis (MS). O'Connell K; Langdon D; Tubridy N; Hutchinson M; McGuigan C Mult Scler Relat Disord; 2015 Nov; 4(6):521-5. PubMed ID: 26590658 [TBL] [Abstract][Full Text] [Related]
4. Validation of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) in the Russian Population. Evdoshenko E; Laskova K; Shumilina M; Nekrashevich E; Andreeva M; Neofidov N; Kalinin I; Nikitchenko D; Rogozina A; Kupaeva A; Bulanov I; Bakirtzis C; Grigoriadis N; Khachanova N; Davydovskaya M; Makshakov G J Int Neuropsychol Soc; 2022 May; 28(5):503-510. PubMed ID: 34132190 [TBL] [Abstract][Full Text] [Related]
5. The Brief International Cognitive Assessment in Multiple Sclerosis (BICAMS): results from the German validation study. Filser M; Schreiber H; Pöttgen J; Ullrich S; Lang M; Penner IK J Neurol; 2018 Nov; 265(11):2587-2593. PubMed ID: 30171410 [TBL] [Abstract][Full Text] [Related]
6. The Norwegian translation of the brief international cognitive assessment for multiple sclerosis (BICAMS). Skorve E; Lundervold AJ; Torkildsen Ø; Myhr KM Mult Scler Relat Disord; 2019 Nov; 36():101408. PubMed ID: 31610403 [TBL] [Abstract][Full Text] [Related]
7. A new assessment tool for patients with multiple sclerosis from Spanish-speaking countries: validation of the Brief International Cognitive Assessment for MS (BICAMS) in Argentina. Vanotti S; Smerbeck A; Benedict RH; Caceres F Clin Neuropsychol; 2016 Oct; 30(7):1023-31. PubMed ID: 27668977 [TBL] [Abstract][Full Text] [Related]
8. Mitoxantrone: a review of its use in multiple sclerosis. Scott LJ; Figgitt DP CNS Drugs; 2004; 18(6):379-96. PubMed ID: 15089110 [TBL] [Abstract][Full Text] [Related]
9. VALIDATION OF THE BRIEF INTERNATIONAL COGNITIVE ASSESSMENT FOR MULTIPLE SCLEROSIS (BICAMS) IN A LARGE COHORT OF RELAPSING-REMITTING MS PATIENTS. Drulović J; Tončev G; Nadj Č; Obradović D; Eraković J; Mesaroš Š; Čukić M; Aleksić D; Andabaka M; Ivanović J; Jovanović A; Kostić M; Marić G; Marković A; Martinović V; Parojčić A; Perić S; Sakalaš L; Suknjaja V; Vesić K; Vojvodić S; Vuković T; Benedict RHB; Pekmezović T Acta Clin Croat; 2022 Mar; 61(1):62-69. PubMed ID: 36398076 [TBL] [Abstract][Full Text] [Related]
10. Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS): Canadian contribution to the international validation project. Walker LA; Osman L; Berard JA; Rees LM; Freedman MS; MacLean H; Cousineau D J Neurol Sci; 2016 Mar; 362():147-52. PubMed ID: 26944137 [TBL] [Abstract][Full Text] [Related]
11. Validation of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) in Greek population with multiple sclerosis. Polychroniadou E; Bakirtzis C; Langdon D; Lagoudaki R; Kesidou E; Theotokis P; Tsalikakis D; Poulatsidou K; Kyriazis O; Boziki M; Papadopoulos G; Boura E; Sintila L; Hatzigeorgiou S; Ziamos C; Ioannidis P; Karacostas D; Grigoriadis N Mult Scler Relat Disord; 2016 Sep; 9():68-72. PubMed ID: 27645348 [TBL] [Abstract][Full Text] [Related]
12. Polish validation of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS battery): correlation of cognitive impairment with mood disorders and fatigue. Betscher E; Guenter W; Langdon DW; Bonek R Neurol Neurochir Pol; 2021; 55(1):59-66. PubMed ID: 33047783 [TBL] [Abstract][Full Text] [Related]
13. Working ability in individuals with different disease courses of multiple sclerosis: Factors beyond physical impairment. Renner A; Baetge SJ; Filser M; Penner IK Mult Scler Relat Disord; 2020 Nov; 46():102559. PubMed ID: 33035965 [TBL] [Abstract][Full Text] [Related]
14. A novel cognitive-behavioral stress management method for multiple sclerosis. A brief report of an observational study. Anagnostouli M; Babili I; Chrousos G; Artemiadis A; Darviri C Neurol Res; 2019 Mar; 41(3):223-226. PubMed ID: 30451648 [TBL] [Abstract][Full Text] [Related]
15. French validation of the Brief International Cognitive Assessment for Multiple Sclerosis. Maubeuge N; Deloire MSA; Brochet B; Erhlé N; Charré-Morin J; Saubusse A; Ruet A; Rev Neurol (Paris); 2021; 177(1-2):73-79. PubMed ID: 32713736 [TBL] [Abstract][Full Text] [Related]
16. Association between cognitive impairment and the disability in people with multiple sclerosis. Suchá B; Šiarnik P; Klobucká S; Turčáni P; Kollár B Neuro Endocrinol Lett; 2023 Jul; 44(5):283-289. PubMed ID: 37524317 [TBL] [Abstract][Full Text] [Related]
18. Validity and Reliability of Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) in Indonesia and the Correlation with Quality of Life. Estiasari R; Fajrina Y; Lastri DN; Melani S; Maharani K; Imran D; Pangeran D; Sitorus F Neurol Res Int; 2019; 2019():4290352. PubMed ID: 31263596 [TBL] [Abstract][Full Text] [Related]
19. The Hungarian validation of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) battery and the correlation of cognitive impairment with fatigue and quality of life. Sandi D; Rudisch T; Füvesi J; Fricska-Nagy Z; Huszka H; Biernacki T; Langdon DW; Langane É; Vécsei L; Bencsik K Mult Scler Relat Disord; 2015 Nov; 4(6):499-504. PubMed ID: 26590654 [TBL] [Abstract][Full Text] [Related]
20. Longitudinal assessment of neurocognitive function in people with relapsing multiple sclerosis initiating alemtuzumab in routine clinical practice: LEM-COG study results. Wilken J; Traboulsee A; Nelson F; Ionete C; Kolind S; Fratto T; Kane R; Gandhi R; Rawlings AM; Roesch N; Ozog MA; DeLuca J; Mult Scler Relat Disord; 2023 May; 73():104677. PubMed ID: 37028124 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]